Literature DB >> 12775989

Low-grade malignant eccrine spiradenoma with systemic metastases.

Niamh Leonard1, David Smith, Paul McNamara.   

Abstract

Malignant eccrine spiradenoma (MES) is a very rare tumor. Tumors can be low grade or high grade. There are nine cases in the literature with systemic metastases. Of these, only one was low grade; the others had obvious features of high-grade malignancy such as pleomorphism, increased mitoses, and abnormal mitoses. Low grade MESs are more difficult to diagnose and are said to have a better prognosis. We report an additional case of low-grade MES with systemic metastases. It had a monotonous appearance with few mitotic figures and minimal pleomorphism. Vascular invasion was seen in both cases of low-grade MES and may be an important prognostic feature.

Entities:  

Mesh:

Year:  2003        PMID: 12775989     DOI: 10.1097/00000372-200306000-00011

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  7 in total

1.  Zosteriform spiradenoma with spiradenocarcinoma: A rare entity.

Authors:  Satish A Adulkar; Atul M Dongre; Uday S Khopkar; Raghuram Maddala; Prachi V Gole; Siddhi Chikhalkar
Journal:  Indian Dermatol Online J       Date:  2015-12

2.  Morphologically low-grade spiradenocarcinoma: a clinicopathologic study of 19 cases with emphasis on outcome and MYB expression.

Authors:  Michiel P J van der Horst; Zlatko Marusic; Jason L Hornick; Boštjan Luzar; Thomas Brenn
Journal:  Mod Pathol       Date:  2015-04-10       Impact factor: 7.842

3.  A rare case of multiple segmental eccrine spiradenomas.

Authors:  Laura Englander; Jason J Emer; Danielle McClain; Bijal Amin; Ryan B Turner
Journal:  J Clin Aesthet Dermatol       Date:  2011-04

4.  Eccrine spiradenoma arising in the breast misdiagnosed as an epidermal inclusion cyst.

Authors:  Hyun Ho Lee; Sung Hee Park; Hye Young Choi; Heung Kyu Park
Journal:  Korean J Radiol       Date:  2011-03-03       Impact factor: 3.500

Review 5.  Current Treatment Options for Cutaneous Adnexal Malignancies.

Authors:  Hiroyuki Goto
Journal:  Curr Treat Options Oncol       Date:  2022-03-26

6.  Sonographic and sonoelastographic findings of a rarely seen soft tissue tumor: eccrine spiradenoma.

Authors:  Mehtap Balaban; Ilkay S Idilman; Ozlem Unal; Ersin Gurkan Dumlu; Aylin Yazgan; Ali Ipek
Journal:  J Med Ultrason (2001)       Date:  2015-05-23       Impact factor: 1.314

7.  Malignant eccrine spiradenoma on the lateral margin of nose as an infrequent localization.

Authors:  Sami Berçin; Ahmet Kutluhan; Ahmet Metin; Dinç Süren
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.